Risk associated with a biopsy diagnosis of atypia has come down on many sides over the past few years. Researchers have now cast risk in more concrete terms in the January 1 issue of the New England Journal of Medicine. Women with atypia, they found, have a 7 percent greater risk of developing a tumor within five years after the biopsy, a 13 percent greater risk after 10 years, and a 30 percent greater risk after 25 years. Researchers at Vanderbilt University have also found a similar risk level.
After a pathology result of atypia, patients can easily be moved to the Awaiting Risk Assessment Queue within Cordata Oncology. This queue can be used for:
- Reminder to review/mark the patient's record that the patient received a risk-based consultation for compliance with NAPBC Standard 1.3 (Remember that NAPBC's Standard 1.3 wants these high risk patients to receive high risk counseling and further the site surveyors want to see it in their medical record review at the time of the site visit). Navigators and support users can attach the note (from an EMR, etc) to the patient record. Depending on when the risk counseling occurs, the note can be placed within the Risk Tools tab or under the Appointments tab.
- Reminder to call the patient for an appointment within a High Risk Clinic. This is a great workflow queue to use if your Center routes patients with high risk paths directly to a High Risk Clinic for a thorough workup of risk (genetic/familial, etc) BEFORE the surgical consult for a wider excision of the lesion.
Our other Queues that support a High Risk Program are:
- All High Risk Participants
- Open High Risk Participants
- High Risk
- Intake Pending
- Testing & Screening
- Awaiting Risk Assessment